COWZ Pacer US Cash Cows 100 ETF
Pacer US Cash Cows 100 TR USD

NAV as of 13-May-2022

48.1978

4 Week: 46.54 - 51.06

52 Week: 41.57 - 51.06

Latest Closing Price

48.21

Premium / Discount

0.09

Expense Ratio

0.49%

Investment Objective

The investment seeks to track the total return performance, before fees and expenses, of the Pacer US Cash Cows 100 Index (the "index"). Under normal circumstances, at least 80% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The index uses an objective, rules-based methodology to provide exposure to large and mid-capitalization U.S. companies with high free cash flow yields. Companies with high free cash flow yields are commonly referred to as "cash cows".

Main Fund Characteristics

Fund Manager:
Pacer
Asset Under Management:
4,959,114,394
Launch Date:
15/12/2016
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
101
Trading Currency:
USD
Style:
Mid Value
Region/Sector/Strategy:
N.A / N.A / N.A
Exchange:
CBOEBZX

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD2.381.341.77
1 Day2.620.000.00
1 Week-1.615.44-0.30
1 Month-4.488.94-0.50
3 Months-0.1711.80-0.01
6 Months1.7114.460.12
1 Year12.6117.250.73
2 Years107.6228.553.77
3 Years73.1745.101.62
5 Years85.9249.901.72
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.000019.5478-9.300823.211511.581342.4772
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.000068.000060.000075.00006.00001.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
23/03/202229/03/20220.1469
22/12/202129/12/20210.2783
22/09/202128/09/20210.1866
20/06/202124/06/20210.1059
21/03/202125/03/20210.1263
20/12/202024/12/20200.2469
20/09/202024/09/20200.2126
21/06/202025/06/20200.1087
22/03/202026/03/20200.2831
23/12/201926/12/20190.2033

Portfolio Data

Total Number of Holdings: 101

Number of Bond Holdings: 0

Number of Equity Holdings: 100

Total Market Value: 4,959,114,394

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Biogen Inc2.547620,293-1276,071,666
2Lam Research Corp2.335019,999-1255,564,922
3AbbVie Inc2.309267,321-4235,503,492
4Bristol-Myers Squibb Company2.242393,493-5885,344,060
5CenturyLink Inc2.1375382,452-2,4055,094,261
6Celgene Corp2.115446,454-2925,041,653
7Cardinal Health Inc2.100699,254-6245,006,372
8Allergan PLC2.082427,837-1754,963,059
9Walgreens Boots Alliance Inc2.067285,862-5404,926,762
10Cummins Inc2.059827,802-1744,908,999

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant6.22
Large39.13
Medium43.46
Small10.67
Micro0.39

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

7.7532

Price/Book*

1.8134

Price/Sales*

0.6655

Price/Cash Flow*

3.5066

Dividend Yield*

2.2587

Growth Measures

Long-Term Earnings

17.0710

Historical Earnings

36.9775

Sales Growth

8.4961

Cash-Flow Growth

20.6953

Book-Value Growth

6.7569

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.